Late Presentation of Acute Hypercapnic Respiratory Failure Carries a High Mortality Risk in COPD Patients Treated With Ward-Based NIV

Respiratory Medicine- United Kingdom

doi 10.1016/j.rmed.2019.04.013

Full Text

Abstract

Available in

Categories

Respiratory Medicine

Date

May 1, 2019

Authors

Samuel P. Trethewey

Rahul Mukherjee

Alice M. Turner

Publisher

Elsevier BV

Related search

Mechanisms of Improvement of Respiratory Failure in Patients With COPD Treated With NIV

International Journal of COPD

Respiratory Medicine

Occupational Health

English

NIV for Acute Respiratory Failure in COPD: High In-Hospital Mortality Is Determined by Patient Selection

European Clinical Respiratory Journal

English

Nasal High-Flow in Acute Hypercapnic Exacerbation of COPD

International Journal of COPD

Respiratory Medicine

Occupational Health

English

Reply: Selection Bias in Study Participants With Acute Hypercapnic Respiratory Failure

American Journal of Respiratory and Critical Care Medicine

Respiratory Medicine

Intensive Care Medicine

English

P42 Factors Affecting the Duration of Acute Non Invasive Ventilation Required in Patients With Acute Hypercapnic Respiratory Failure

Respiratory Medicine

English

Initial pH and Mortality in Patients With Exacerbations of COPD and Pneumonia Treated With NIV in a Teaching Hospital Critical Care Unit

Intensive Care Medicine

English

Reduction of PaCO2 by High-Flow Nasal Cannula in Acute Hypercapnic Respiratory Failure Patients Receiving Conventional Oxygen Therapy

Acute and Critical Care

Critical Care Nursing

Intensive Care Medicine

English

Base Excess, a Marker of Chronic Hypercapnic Respiratory Failure and Predictor of Survival in COPD

European Respiratory Review

Respiratory Medicine

English

NIV Should Be Delivered in Do-Not-Intubate Patients in Acute Respiratory Failure, but How?

Intensive Care Medicine

Intensive Care Medicine

English